We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Huntington Bancshares
HBAN
$35.5B
| $25.8M | 0.04% |
1,638,399
-173,877
| -10% | -$2.61M |
|
477
Encompass Health
EHC
$12.4B
| $25.7M | 0.03% |
394,535
-9,847
| -2% | -$642K |
|
478
First Horizon
FHN
$12.1B
| $25.7M | 0.03% |
1,518,471
-1,918
| -0.1% | -$30.3K |
|
479
Aecom
ACM
$9.75B
| $25.6M | 0.03% |
399,135
-16,489
| -4% | -$938K |
|
480
Deckers Outdoor
DECK
$13.3B
| $25.6M | 0.03% |
464,598
-9,216
| -2% | -$492K |
|
481
Okta
OKTA
$25.8B
| $25.5M | 0.03% |
115,630
-7,768
| -6% | -$1.95M |
|
482
American Airlines Group
AAL
$10.6B
| $25.5M | 0.03% |
1,065,436
+52,500
| +5% | +$1.01M |
|
483
RingCentral
RNG
$5.28B
| $25.4M | 0.03% |
85,421
-2,971
| -3% | -$1.09M |
|
484
Viatris
VTRS
$18.9B
| $25.1M | 0.03% |
1,795,366
-102,563
| -5% | -$1.67M |
|
485
Jack Henry & Associates
JKHY
$11.1B
| $25M | 0.03% |
165,076
-6,132
| -4% | -$935K |
|
486
Quanta Services
PWR
$101B
| $25M | 0.03% |
284,307
-12,874
| -4% | -$1.03M |
|
487
Chemed
CHE
$7.22B
| $25M | 0.03% |
54,321
+5,364
| +11% | +$2.63M |
|
488
Pultegroup
PHM
$25.3B
| $24.8M | 0.03% |
473,157
-21,235
| -4% | -$991K |
|
489
Cincinnati Financial
CINF
$27.1B
| $24.7M | 0.03% |
239,921
-28,973
| -11% | -$2.78M |
|
|
490
Neurocrine Biosciences
NBIX
$16.6B
| $24.7M | 0.03% |
254,161
+140,532
| +124% | +$14.7M |
|
491
Middleby
MIDD
$6.08B
| $24.7M | 0.03% |
149,046
-921
| -0.6% | -$136K |
|
492
Bath & Body Works
BBWI
$4.1B
| $24.7M | 0.03% |
493,074
-16,815
| -3% | -$692K |
|
493
Omega Healthcare
OHI
$14.7B
| $24.6M | 0.03% |
672,423
+10,715
| +2% | +$394K |
|
494
Jazz Pharmaceuticals
JAZZ
$16.7B
| $24.6M | 0.03% |
149,835
-860
| -0.6% | -$142K |
|
|
Y
495
DELISTED
Alleghany Corp
Y
| $24.5M | 0.03% |
39,127
-1,465
| -4% | -$906K |
|
496
Diamondback Energy
FANG
$52.7B
| $24.5M | 0.03% |
332,923
+44,421
| +15% | +$3.04M |
|
497
C.H. Robinson
CHRW
$17.5B
| $24.4M | 0.03% |
256,156
-14,356
| -5% | -$1.34M |
|
498
Alliant Energy
LNT
$18B
| $24.4M | 0.03% |
450,577
+541
| +0.1% | +$26.9K |
|
499
J.M. Smucker
SJM
$12.8B
| $24.4M | 0.03% |
192,708
-36,328
| -16% | -$4.29M |
|
|
AXON
500
Axon Enterprise
AXON
$46.4B
| $24.3M | 0.03% |
170,911
-2,346
| -1% | -$366K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.